Diabetes and failure of axon regeneration in peripheral neurons

References

• Zochodne DW. Neurobiology of Peripheral Nerve Regeneration. Cambridge University Press, Cambridge, UK (2008).
   Google Scholar
• Borghini I, Ania-Lahuerta A, Regazzi R et al. α, β I, β II, δ, and e protein kinase C isoforms and compound activity in the sciatic nerve of normal and diabetic rats. J. Neurochem.62(2), 686–696 (1994).
   PubMed Web of Science ®Google Scholar
• Greene DA, Lattimer SA, Sima AA. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med.316(10), 599–606 (1987).
   PubMed Web of Science ®Google Scholar
• Gupta S, Sussman I, McArthur CS, Tornheim K, Cohen RA, Ruderman NB. Endothelium-dependent inhibition of Na(+)-K+ ATPase activity in rabbit aorta by hyperglycemia. Possible role of endothelium-derived nitric oxide. J. Clin. Invest.90(3), 727–732 (1992).
   PubMed Web of Science ®Google Scholar
• Roberts RE, McLean WG. Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats. Brain Res.754(1–2), 147–156 (1997).
   PubMed Web of Science ®Google Scholar
• Sima AAF, Brismar T, Yagihashi S. Neuropathies encountered in the spontaneously diabetic BB Wistar rat. In: Diabetic Neuropathy. Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D Jr (Eds). WB Saunders, Toronto, Canada 253–259 (1987).
   Google Scholar
• Kamijo M, Merry AC, Akdas G, Cherian PV, Sima AA. Nerve fiber regeneration following axotomy in the diabetic biobreeding Worcester rat: the effect of ARI treatment. J. Diabetes Complications10(4), 183–191 (1996).
   PubMed Web of Science ®Google Scholar
• Sima AA, Bril V, Nathaniel V et al. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N. Engl. J. Med.319(9), 548–555 (1988).
   PubMed Web of Science ®Google Scholar
• Zochodne DW. Nerve and ganglion blood flow in diabetes: an appraisal. In: Neurobiology of Diabetic Neuropathy. Tomlinson D (Ed.). Academic Press, CA, USA 161–202 (2002).
   Google Scholar
• Brewster WJ, Fernyhough P, Diemel LT, Mohiuddin L, Tomlinson DR. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci.17(8), 321–325 (1994).
   PubMed Web of Science ®Google Scholar
• Hellweg R, Raivich G, Hartung H-D, Hock C, Kreutzberg GW. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp. Neurol.130, 24–30 (1994).
   PubMed Web of Science ®Google Scholar
• Hellweg R, Wohrle M, Hartung H-D, Stracke H, Hock C, Federlin K. Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogeneic pancreatic islet tranplantation. Neurosci. Lett.125(1), 1–4 (1991).
   PubMed Web of Science ®Google Scholar
• Fernyhough P, Diemel LT, Brewster WJ, Tomlinson DR. Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: effects of insulin treatment. Neuroscience62(2), 337–344 (1994).
   PubMed Web of Science ®Google Scholar
• Mizisin AP, DiStefano PS, Liu X, Garrett DN, Tonra JR. Decreased accumulation of endogenous brain-derived neurotrophic factor against constricting sciatic nerve ligatures in streptozotocin-diabetic and galactose-fed rats. Neurosci. Lett.263(2–3), 149–152 (1999).
   PubMed Web of Science ®Google Scholar
• Zochodne DW, Verge VMK, Cheng C, Sun H, Johnston J. Does diabetes target ganglion neurons? Progressive sensory neuron involvement in long term experimental diabetes. Brain124, 2319–2334 (2001).
   PubMed Web of Science ®Google Scholar
• Cheng C, Zochodne DW. Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes52, 2363–2371 (2003).
   PubMed Web of Science ®Google Scholar
• Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol. Dis.6(5), 347–363 (1999).
   PubMed Web of Science ®Google Scholar
• Sasaki H, Schmelzer JD, Zollman PJ, Low PA. Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats. Acta Neuropathol.93(2), 118–128 (1997).
   PubMed Web of Science ®Google Scholar
• Kennedy JM, Zochodne DW. Experimental diabetic neuropathy and spontaneous recovery: is there irreparable damage? Diabetes54(3), 830–837 (2005).
   PubMed Web of Science ®Google Scholar
• Ramji N, Toth C, Kennedy J, Zochodne DW. Does diabetes mellitus target motor neurons? Neurobiol. Dis.26, 301–311 (2007).
   PubMed Web of Science ®Google Scholar
• Kamiya H, Zhangm W, Sima AA. Apoptotic stress is counterbalanced by survival elements preventing programmed cell death of dorsal root ganglions in subacute Type 1 diabetic BB/Wor rats. Diabetes54(11), 3288–3295 (2005).
   PubMed Web of Science ®Google Scholar
• Verge VM, Gratto KA, Karchewski LA, Richardson PM. Neurotrophins and nerve injury in the adult. Philos. Trans. R Soc. Lond. B Biol. Sci.351(1338), 423–430 (1996).
   PubMed Web of Science ®Google Scholar
• Xu G, Pierson CR, Murakawa Y, Sima AA. Altered tubulin and neurofilament expression and impaired axonal growth in diabetic nerve regeneration. J. Neuropathol. Exp. Neurol.61(2), 164–175 (2002).
   PubMed Web of Science ®Google Scholar
• Price SA, Hounsom L, Purves-Tyson TD, Fernyhough P, Tomlinson DR. Activation of JNK in sensory neurons protects against sensory neuron cell death in diabetes and on exposure to glucose/oxidative stress in vitro. Ann. NY Acad. Sci.1010, 95–99 (2003).
   PubMed Web of Science ®Google Scholar
• Zherebitskaya E, Akude E, Smith DR, Fernyhough P. Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress. Diabetes58(6), 1356–1364 (2009).
   PubMed Web of Science ®Google Scholar
• McDonald DS, Zochodne DW. An injectable nerve regeneration chamber for studies of unstable soluble growth factors. J. Neurosci. Methods122(2), 171–178 (2003).
   PubMed Web of Science ®Google Scholar
• Zochodne DW, Guo G, Magnowski B, Bangash M. Regenerative failure of diabetic nerves bridging transection injuries. Diabetes Metab. Res. Rev.23(6), 490–496 (2007).
   PubMed Web of Science ®Google Scholar
• Jiang Y, Calcutt NA, Ramos KM, Mizisin AP. Novel sites of aldose reductase immunolocalization in normal and streptozotocin-diabetic rats. J. Peripher. Nerv. Syst.11(4), 274–285 (2006).
   PubMed Web of Science ®Google Scholar
• Kalichman MW, Powell HC, Mizisin AP. Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol.95(1), 47–56 (1998).
   PubMed Web of Science ®Google Scholar
• Mizisin AP, Li L, Calcutt NA. Sorbitol accumulation and transmembrane efflux in osmotically stressed JS1 schwannoma cells. Neurosci. Lett.229(1), 53–56 (1997).
   PubMed Web of Science ®Google Scholar
• Mizisin AP, Powell HC. Schwann cell injury is attenuated by aldose reductase inhibition in galactose intoxication. J. Neuropathol. Exp. Neurol.52(1), 78–86 (1993).
   PubMed Web of Science ®Google Scholar
• Toth CC, Willis D, Twiss JL et al. Locally synthesized calcitonin gene-related peptide has a critical role in peripheral nerve regeneration. J. Neuropathol. Exp. Neurol.68(3), 326–337 (2009).
   PubMed Web of Science ®Google Scholar
• Kennedy JM, Zochodne DW. Influence of experimental diabetes on the microcirculation of injured peripheral nerve. Functional and morphological aspects. Diabetes51, 2233–2240 (2002).
   PubMed Web of Science ®Google Scholar
• Mack TG, Reiner M, Beirowski B et al. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci.4(12), 1199–1206 (2001).
   PubMed Web of Science ®Google Scholar
• Chen S, Bisby MA. Impaired motor axon regeneration in the C57BL/Ola mouse. J. Comp. Neurol.333(3), 449–454 (1993).
   PubMed Web of Science ®Google Scholar
• Wang MS, Fang G, Culver DG, Davis AA, Rich MM, Glass JD. The WldS protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy. Ann. Neurol.50(6), 773–779 (2001).
   PubMed Web of Science ®Google Scholar
• Levy D, Kubes P, Zochodne DW. Delayed peripheral nerve degeneration, regeneration, and pain in mice lacking inducible nitric oxide synthase. J. Neuropathol. Exp. Neurol.60(5), 411–421 (2001).
   PubMed Web of Science ®Google Scholar
• Kennedy JM, Zochodne DW. The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. Brain123, 2118–2129 (2000).
   PubMed Web of Science ®Google Scholar
• Diamond J, Holmes M, Coughlin M. Endogenous NGF and nerve impulses regulate the collateral sprouting of sensory axons in the skin of the adult rat. J. Neurosci.12(4), 1454–1466 (1992).
   PubMed Web of Science ®Google Scholar
• Theriault M, Dort J, Sutherland G, Zochodne DW. A prospective quantitative study of sensory deficits after whole sural nerve biopsies in diabetic and nondiabetic patients. Surgical approach and the role of collateral sprouting. Neurology50(2), 480–484 (1998).
   PubMed Web of Science ®Google Scholar
• Tomlinson DR, Fernyhough P, Diemel LT. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes46(2), S43–S49 (1997).
   Web of Science ®Google Scholar
• Tomlinson DR, Fernyhough P, Diemel LT. Neurotrophins and peripheral neuropathy. Philos. Trans. R Soc. Lond. B Biol. Sci.351(1338), 455–462 (1996).
   PubMed Web of Science ®Google Scholar
• Delcroix JD, Tomlinson DR, Fernyhough P. Diabetes and axotomy-induced deficits in retrograde axonal transport of nerve growth factor correlate with decreased levels of p75LNTR protein in lumbar dorsal root ganglia. Brain Res. Mol. Brain Res.51(1–2), 82–90 (1997).
   PubMedGoogle Scholar
• Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res.634, 7–12 (1994).
   PubMed Web of Science ®Google Scholar
• Apfel SC, Kessler JA. Neurotrophic factors in the therapy of peripheral neuropathy. Baillieres Clin. Neurol.4(3), 593–606 (1995).
   PubMedGoogle Scholar
• Christianson JA, Riekhof JT, Wright DE. Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp. Neurol.179(2), 188–199 (2003).
   PubMed Web of Science ®Google Scholar
• Apfel SC, Schwartz S, Adornato BT et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA284(17), 2215–2221 (2000).
   PubMed Web of Science ®Google Scholar
• Zochodne DW, Said G. Recombinant human nerve growth factor and diabetic polyneuropathy. Neurology51(3), 662–663 (1998).
   PubMed Web of Science ®Google Scholar
• Goss JR, Goins WF, Lacomis D, Mata M, Glorioso JC, Fink DJ. Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes51(7), 2227–2232 (2002).
   PubMed Web of Science ®Google Scholar
• Price SA, Dent C, Duran-Jimenez B et al. Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy. Diabetes55(6), 1847–1854 (2006).
   PubMed Web of Science ®Google Scholar
• Ishii DN. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res. Brain Res. Rev.20, 47–67 (1995).
   PubMed Web of Science ®Google Scholar
• Ishii DN. Insulin and related neurotrophic factors in diabetic neuropathy. Diabet. Med.10(2), S14–S15 (1993).
   Google Scholar
• Sugimoto K, Murakawa Y, Zhang W, Xu G, Sima AA. Insulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms. Diabetes Metab. Res. Rev.16(5), 354–363 (2000).
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Murakawa Y, Sima AA. Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord. J. Peripher. Nerv. Syst.7(1), 44–53 (2002).
   PubMed Web of Science ®Google Scholar
• Fernyhough P, Mill JF, Roberts JL, Ishii DN. Stabilization of tubulin mRNAs by insulin and insulin-like growth factor I during neurite formation. Brain Res. Mol. Brain Res.6(2–3), 109–120 (1989).
   PubMedGoogle Scholar
• Xu QG, Li X-Q, Kotecha SA, Cheng C, Sun HS, Zochodne DW. Insulin as an in vivo growth factor. Exp. Neurol.188(1), 43–51 (2004).
   PubMed Web of Science ®Google Scholar
• Toth C, Brussee V, Martinez JA, McDonald D, Cunningham FA, Zochodne DW. Rescue and regeneration of injured peripheral nerve axons by intrathecal insulin. Neuroscience139(2), 429–449 (2006).
   PubMed Web of Science ®Google Scholar
• Sima AA, Kamiya H. Diabetic neuropathy differs in Type 1 and Type 2 diabetes. Ann. NY Acad. Sci.1084, 235–249 (2006).
   PubMed Web of Science ®Google Scholar
• Brussee V, Cunningham FA, Zochodne DW. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes53(7), 1824–1830 (2004).
   PubMed Web of Science ®Google Scholar
• Toth C, Brussee V, Zochodne DW. Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia49(5), 1081–1088 (2006).
   PubMed Web of Science ®Google Scholar